Peter Welford

Stock Analyst at Jefferies

(2.29)
# 2,295
Out of 4,880 analysts
13
Total ratings
66.67%
Success rate
8.09%
Average return

Stocks Rated by Peter Welford

GSK plc
Nov 12, 2024
Downgrades: Hold
Price Target: n/a
Current: $38.95
Upside: -
Novartis AG
Sep 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $123.10
Upside: -
AstraZeneca
Jan 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $71.46
Upside: -
Galapagos NV
Jan 23, 2023
Upgrades: Hold
Price Target: $49$47
Current: $27.89
Upside: +69.24%
Genmab
Sep 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $20.75
Upside: -